Key Developments: Vitrolife AB (VITRO.BE)

VITRO.BE on Berlin Stock Exchange

16.01EUR
10:43am EST
Price Change (% chg)

€0.15 (+0.95%)
Prev Close
€15.86
Open
€15.90
Day's High
€16.07
Day's Low
€15.90
Volume
--
Avg. Vol
16
52-wk High
€17.07
52-wk Low
€9.25

Search Stocks

Latest Key Developments (Source: Significant Developments)

Vitrolife AB completes Unisense FertiliTech purchase
Wednesday, 26 Nov 2014 10:40am EST 

Vitrolife AB:Completes the acquisition of Unisense FertiliTech A/S and has therefore resolved to carry out a non-cash issue.In line with the authorization granted by the Annual General Meeting has resolved to carry out a non-cash issue of 1,879,179 shares, constituting part of the purchase sum for the acquisition of FertiliTech.It is expected that the transaction will affect Vitrolife's EBITDA per share negatively during 2014 and 2015 but contribute positively as from 2016 as a result of increased sales due to the use of Vitrolife's global market presence and cost synergies.  Full Article

Vitrolife AB acquires Unisense FertiliTech A/S
Wednesday, 5 Nov 2014 02:30am EST 

Vitrolife AB:Entered into an agreement to acquire all shares of Unisense FertiliTech A/S (FertiliTech), market within field of embryo monitoring, time-lapse, for IVF.  Full Article

Vitrolife AB announces details on FY 2013 dividend and elects Deloitte AB as auditor
Tuesday, 6 May 2014 02:30am EDT 

Vitrolife AB:Says board’s proposed dividend of 1.00 Swedish crown per share for the financial year 2013 was approved by annual general meeting.May 8 was adopted as record day.Says annual general meeting elected Deloitte AB, with authorized public accountant Jan Nilsson as head auditor, and authorized public accountant Fredrik Jonsson as auditors for a term of three years.  Full Article

Vitrolife AB proposes FY 2013 dividend of 1.00 Swedish crown per share
Thursday, 6 Feb 2014 02:30am EST 

Vitrolife AB:Says its Board proposes a dividend of 1.00 Swedish crown per share for fiscal year 2013.Says it paid a dividend of 0.60 Swedish crown per share for fiscal year 2012.  Full Article

Vitrolife AB and Biolamina AB Extend Collaboration; Vitrolife Acquires Stake in Biolamina
Wednesday, 13 Nov 2013 02:30am EST 

Vitrolife AB announced that it has collaborated with the Stockholm-based Biolamina AB within the stem-cell field since 2012. The companies have decided to extend their collaboration and Vitrolife has invested in Biolamina together with the company’s present owners. During spring the collaboration resulted in the launch of a new freeze medium for stem cells, FREEZEstem, which has been developed and produced by Vitrolife and is marketed globally by Biolamina. The companies have decided to extend their collaboration and Vitrolife has invested SEK 4 million in Biolamina in a directed new share issue, which gives Vitrolife a 4.6% participation in the company. Vitrolife takes possession of the shares in Biolamina as soon as the share issue has been registered at the Swedish Companies Registration Office. The investment is financed through Vitrolife’s cash reserves. Vitrolife will also be represented on the company’s Board in the future.  Full Article

Vitrolife AB Appoints Carsten Browall as Chairman
Tuesday, 30 Apr 2013 02:30am EDT 

Vitrolife AB announced that during the Company's Annual General Meeting, Carsten Browall was elected the new Chairman of the Board.  Full Article

Vitrolife AB Acquires Remaining Shares in HertArt ApS
Tuesday, 2 Apr 2013 03:00am EDT 

Vitrolife AB announced that in 2010, it entered into a collaboration agreement with the Danish company HertArt ApS with the aim of developing a new range of disposable plastic products for IVF called Labware. Vitrolife acquired 25% of the shares in HertArt as part of the collaboration agreement. Vitrolife has now exercised an option to acquire all the shares in the company. HertArt has developed and registered a portfolio of products for IVF such as cultivation dishes, test tubes and pipettes. Vitrolife plans to launch the product range in 2013. The purchase sum amounted to DKK 2 million and may be increased to DKK 3 million if certain defined sales objectives are achieved. The initial purchase sum of DKK 2 million is to be paid in cash and financed from Vitrolife’s cash in hand. It is estimated that the acquisition will only entail a marginal impact on Vitrolife’s earnings per share for 2013.  Full Article

Vitrolife AB Announces Details on FY 2012 Dividend
Tuesday, 26 Mar 2013 03:30am EDT 

Vitrolife AB announced that its Board proposes a dividend of SEK 0.60 per share for fiscal year 2012 and May 3, 2013 as the record date, which means that the last day of trading of shares including dividend is April 29, 2013. It is expected that the dividend will be delivered to shareholders on May 8, 2013.  Full Article

Vitrolife AB's Chairman Patrik Tigerschiold to Step Down
Monday, 25 Mar 2013 11:30am EDT 

Vitrolife AB announced that Patrik Tigerschiold, Chairman of the Board of Directors of the Company, has declined re-election at the Annual General Meeting of the Company to be held on April 19, 2013.  Full Article

Vitrolife AB Proposes FY 2012 Dividend of SEK 0.60 per Share
Thursday, 7 Feb 2013 02:30am EST 

Vitrolife AB announced that its Board proposes fiscal year 2012 dividend of SEK 0.60 per share. For fiscal year 2011, the Company also paid a dividend of SEK 0.60 per share.  Full Article

BRIEF-Vitrolife Q3 operating profit sharply up

* Q3 operating income (EBIT) amounted to sek 44 (23) million Source text for Eikon: Further company coverage:

Search Stocks